108 related articles for article (PubMed ID: 26603170)
1. Artemisinin-based combination therapy for knowlesi malaria.
Ramharter M
Lancet Infect Dis; 2016 Feb; 16(2):134-6. PubMed ID: 26603170
[No Abstract] [Full Text] [Related]
2. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial.
Grigg MJ; William T; Menon J; Dhanaraj P; Barber BE; Wilkes CS; von Seidlein L; Rajahram GS; Pasay C; McCarthy JS; Price RN; Anstey NM; Yeo TW
Lancet Infect Dis; 2016 Feb; 16(2):180-188. PubMed ID: 26603174
[TBL] [Abstract][Full Text] [Related]
3. A study protocol for a randomised open-label clinical trial of artesunate-mefloquine versus chloroquine in patients with non-severe Plasmodium knowlesi malaria in Sabah, Malaysia (ACT KNOW trial).
Grigg MJ; William T; Dhanaraj P; Menon J; Barber BE; von Seidlein L; Rajahram G; Price RN; Anstey NM; Yeo TW
BMJ Open; 2014 Aug; 4(8):e006005. PubMed ID: 25138814
[TBL] [Abstract][Full Text] [Related]
4. The Treatment of Plasmodium knowlesi Malaria.
Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM
Trends Parasitol; 2017 Mar; 33(3):242-253. PubMed ID: 27707609
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region.
Alecrim M das G; Alecrim W; Macêdo V
Rev Soc Bras Med Trop; 1999; 32(1):67-8. PubMed ID: 9927829
[TBL] [Abstract][Full Text] [Related]
6. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human Plasmodium knowlesi infections to anti-malarials.
Fatih FA; Staines HM; Siner A; Ahmed MA; Woon LC; Pasini EM; Kocken CH; Singh B; Cox-Singh J; Krishna S
Malar J; 2013 Nov; 12():425. PubMed ID: 24245918
[TBL] [Abstract][Full Text] [Related]
9. Artemisinins in malaria treatment in the UK.
Drug Ther Bull; 2010 Nov; 48(11):129-32. PubMed ID: 21057033
[TBL] [Abstract][Full Text] [Related]
10. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys.
Shi YL; Li GF; Zhao JH; Yang JD; Ding DB
Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):755-8. PubMed ID: 10678113
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activity of mefloquine and chloroquine against blood induced Plasmodium knowlesi infection in rhesus monkeys.
Singh PP; Dutta GP
Indian J Med Res; 1981 Jan; 73 Suppl():23-8. PubMed ID: 6974694
[No Abstract] [Full Text] [Related]
13. An autochthonous case of severe Plasmodium knowlesi malaria in Thailand.
Nakaviroj S; Kobasa T; Teeranaipong P; Putaporntip C; Jongwutiwes S
Am J Trop Med Hyg; 2015 Mar; 92(3):569-72. PubMed ID: 25535314
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
[TBL] [Abstract][Full Text] [Related]
15. Malaria: uncomplicated, caused by Plasmodium falciparum.
Taylor-Robinson D; Jones K; Garner P
Clin Evid; 2005 Jun; (13):988-1009. PubMed ID: 16135285
[No Abstract] [Full Text] [Related]
16. Mefloquine resistance reversal action of ketoconazole - a cytochrome P450 inhibitor, against mefloquine-resistant malaria.
Tripathi R; Awasthi A; Dutta GP
Parasitology; 2005 May; 130(Pt 5):475-9. PubMed ID: 15991489
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Jansen FH; Lesaffre E; Penali LK; Zattera MJ; Die-Kakou H; Bissagnene E
Am J Trop Med Hyg; 2007 Dec; 77(6):1005-9. PubMed ID: 18165512
[TBL] [Abstract][Full Text] [Related]
18. Are we losing artemisinin combination therapy already?
Duffy PE; Sibley CH
Lancet; 2005 Dec; 366(9501):1908-9. PubMed ID: 16325683
[No Abstract] [Full Text] [Related]
19. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
[TBL] [Abstract][Full Text] [Related]
20. Artesunate combinations for malaria.
Hoshen M
Lancet; 2004 Feb; 363(9410):737. PubMed ID: 15001342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
